GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shengda Bio-Pharm Co Ltd (SHSE:603079) » Definitions » Accounts Receivable

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Accounts Receivable : ¥157.9 Mil (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Shengda Bio-Pharm Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Zhejiang Shengda Bio-Pharm Co's accounts receivables for the quarter that ended in Sep. 2024 was ¥157.9 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Zhejiang Shengda Bio-Pharm Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 was 64.22.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Zhejiang Shengda Bio-Pharm Co's Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was ¥-0.12.


Zhejiang Shengda Bio-Pharm Co Accounts Receivable Historical Data

The historical data trend for Zhejiang Shengda Bio-Pharm Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shengda Bio-Pharm Co Accounts Receivable Chart

Zhejiang Shengda Bio-Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104.30 112.88 130.68 132.12 116.93

Zhejiang Shengda Bio-Pharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 131.51 116.93 125.89 149.10 157.92

Zhejiang Shengda Bio-Pharm Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Zhejiang Shengda Bio-Pharm Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Zhejiang Shengda Bio-Pharm Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=157.919/224.395*91
=64.22

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Zhejiang Shengda Bio-Pharm Co's accounts receivable are only considered to be worth 75% of book value:

Zhejiang Shengda Bio-Pharm Co's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(245.777+0.75 * 157.919+0.5 * 204.974-465.535
-0-21.04)/171.189
=-0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Zhejiang Shengda Bio-Pharm Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Zhejiang Shengda Bio-Pharm Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Shengda Bio-Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
No.789, Renmin East Road, Chicheng Street, Tiantai County, Zhejiang Province, Hangzhou, CHN, 317200
Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid and other vitamin products, as well as nisin and natamycin.
Executives
Pang Ai Ming Director
Zhu Yong Gang Director

Zhejiang Shengda Bio-Pharm Co Headlines

No Headlines